Entorhinal cortex β-amyloid load in individuals with mild cognitive impairment

Experimental Neurology

Volumn 158, Issue 2, 1999, Pages 469-490

  Mufson, E J ^a   Chen, E Y ^a   Cochran, E J ^a   Beckett, L A ^a   Bennett, D A ^a   Kordower, J H ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Amyloid; Cortex; Dementia; Histochemistry; Plaques; Tangles

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL;

EID: 0032864612     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7086     Document Type: Article

References (95)

1. Albert M., Smith L. A., Scherr P. A., Taylor J. O., Evans D. A., Funkenstein H. H. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int. J. Neurosci. 57:1991;167-178.
2. Arriagada P. V., Growdon J. H., Hedley-Whyte E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
3. Bahr B. A., Abai B., Gall C. M., Vanderklish P. W., Hoffman K. B., Lynch G. Induction of beta-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129:1994;81-94.
4. Bartoo G. T., Nochlin D., Chang D., Kim Y., Sumi S. M. The mean A beta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;531-540.
5. Beach T. G., Honer W. G., Hughes L. H. Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: The preclinical stage of Alzheimer's disease. Acta Neuropathol. (Berl.). 93:1997;146-153.
6. Beckett L. A., Wilson R. S., Bennett D. A., Morris M. C. Around the WORLD backward: An algorithm for scoring the MMSE WORLD item. Neurology. 48:1997;1733-1734.
7. Bennett D. A., Cochran E. J., Saper C. B., Leverenz J. B., Gilley D. W., Wilson R. S. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol. Aging. 14:1993;589-596.
8. Bennett D. A., Shannon K. M., Beckett L. A., Goetz C. G., Wilson R. S. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology. 49:1997;1580-1587.
9. Bennett D. A., Shannon K. M., Beckett L. A., Wilson R. S. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J. Gerontology: Med. Sci. 54:1999.
10. Benton A. L., Varney N. R., Hamsher K. D. Visuospatial judgment. A clinical test. Arch. Neurol. 35:1978;364-367.
11. Blackford R. C., Larue A. Criteria for diagnosing age-associated memory impairment: Proposed improvements form the field. Dev. Neuropsychol. 5:1989;295-306.
12. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry. 114:1968;797-811.
13. Borchelt D. R., Ratovitski T., Van Lare J., Lee M. K., Gonzales V., Jenkins N. A., Copeland N. G., Price D. L., Sisodia S. S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
14. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.). 82:1991;239-259.
15. Brady D. R., Mufson E. J. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease. J. Comp. Neurol. 305:1991;489-507.
16. Cochran E. J., Fox J. H., Mufson E. J. Severe panencephalic Pick's disease with Alzheimer's disease-like neuropil threads and synaptophysin immunoreactivity. Acta Neuropathol. (Berl.). 88:1994;479-484.
17. Cochran E. J., Bennett D. A., Beckett L. A., Nainys M., Mufson E. J. Index of paired helical filament pathology in the temporal lobe: Relation to braak stage and cognitive function in the religious study. J. Neuropathol. Exp. Neurol. 56:1997;615.
18. Cooper J. A., Sagar H. J. Incidental and intentional recall in Parkinson's disease: An account based on diminished attentional resources. J. Clin. Exp. Neuropsychol. 15:1993;713-731.
19. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families [see comments]. Science. 261:1993;921-923.
20. Craik F. A functional account of age differences in memory. Klix, Hagendorf H. Human Memory and Cognitive Capabilities: Mechanisms and Performances. 1986;409-422 Elsevier, Amsterdam.
21. Crook T., Bartus R. T., Ferris S. H. Age-associated impairment: Proposed diagnostic criteria and measures of clinical change. Dev. Neuropsychol. 2:1986;261-276.
22. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdeu J., Kawas C., Aronson M., Wolfson L. Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 38:1988;1682-1687.
23. Crystal H. A., Dickson D. W., Sliwinski M. J., Lipton R. B., Grober E., Marks-Nelson H., Antis P. Pathological markers associated with normal aging and dementia in the elderly. Ann. Neurol. 34:1993;566-573.
24. Crystal H. A., Dickson D., Sliwinski M., Masur D., Blau A., Lipton R. B. Associations of status and change measures of neuropsychological function with pathologic changes in elderly, originally nondemented subjects. Arch. Neurol. 53:1996;82-87.
25. Cummings B. J., Cotman C. W. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet. 346:1995;1524-1528.
26. Cummings B. J., Pike C. J., Shankle R., Cotman C. W. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease [see comments]. Neurobiol. Aging. 17:1996;921-933.
27. Dekosky S. T., Scheff S. W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol. 27:1990;457-464.
28. Devanand D. P., Folz M., Gorlyn M., Moeller J. R., Stern Y. Questionable dementia: Clinical course and predictors of outcome. J. Am. Geriatr. Soc. 45:1997;321-328.
29. Dickson D. W., Crystal H. A., Mattiace L. A., Masur D. M., Blau A. D., Davies P., Yen S. H., Aronson M. K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13:1992;179-189.
30. Ebly E. M., Hogan D. B., Parhad I. M. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch. Neurol. 52:1995;612-619.
31. Ekstrom, R. B, J. W. French, H. H. Harman, and, D. Derman, 1976, Manual for kit of factor-referenced cognitive tests, Princeton, Educational Testing Service.
32. Flicker C., Ferris S. H., Reisberg B. Mild cognitive impairment in the elderly: Predictors of dementia. Neurology. 41:1991;1006-1009.
33. Folstein M. F., Folstein S. E., Mchugh P. R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
34. Goldstein L. B., Bertels C., Davis J. N. Interrater reliability of the NIH stroke scale. Arch. Neurol. 46:1989;660-662.
35. Goldstein L. B., Samsa G. P. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 28:1997;307-310.
36. Gomez-Isla T., Price J. L., Mckeel D. W. J., Morris J. C., Growdon J. H., Hyman B. T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
37. Goodglass H. Kaplan. Assessment of Aphasia and Related Disorders. 1972;Lea & Febiger, Philadelphia.
38. Hancock M. B. A serotonin-immunoreactive fiber system in the dorsal columns of the spinal cord. Neurosci. Lett. 31:1982;247-252.
39. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12:1991;383-388.
40. Hardy J., Duff K., Hardy K. G., Perez-Tur J., Hutton M. Genetic disection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau. Nature Neurosci. 1:1998;355-358.
41. Haroutunian V., Perl D. P., Purohit D. P., Marin D., Khan K., Lantz M., Davis K. L., Mohs R. C. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease [see comments]. Arch. Neurol. 55:1998;1185-1191.
42. Heinonen O., Lehtovirta M., Soininen H., Helisalmi S., Mannermaa A., Sorvari H., Kosunen O., Paljarvi L., Ryynanen M., Riekkinen P. J. S. Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele. Neurobiol. Aging. 16:1995;505-513.
43. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
44. Hof P. R., Bierer L. M., Perl D. P., Delacourte A., Buee L., Bouras C., Morrison J. H. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. Arch. Neurol. 49:1992;946-953.
45. Holcomb L., Gordon M. N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C. M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:1998;97-100.
46. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice [see comments]. Science. 274:1996;99-102.
47. Hyman B. T., Van Horsen G. W., Damasio A. R., Barnes C. L. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170.
48. Hyman B. T., Van Hoesen G. W., Kromer L. J., Damasio A. R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
49. Itoh Y., Yamada M. Apolipoprotein E and the neuropathology of dementia [letter; comment]. N. Engl. J. Med. 334:1996;599-600.
50. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43). Neuron. 13:1994;45-53.
51. Iwatsubo T., Mann D. M., Odaka A., Suzuki N., Ihara Y. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome [see comments]. Ann. Neurol. 37:1995;294-299.
52. Kanne S. M., Balota D. A., Storandt M., Mckeel D. W. J., Morris J. C. Relating anatomy to function in Alzheimer's disease: Neuropsychological profiles predict regional neuropathology 5 years later. Neurology. 50:1998;979-985.
53. Katzman R., Terry R., Deteresa R., Brown T., Davies P., Fuld P., Renbing X., Peck A. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23:1988;138-144.
54. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology. 43:1993;13-20.
55. Kral V. A. Senescent forgetfulness: Benign and malignant. Can. Med. Assoc. J. 86:1962;257-260.
56. Laferla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., Jay G. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:1995;21-30.
57. Lemere C. A., Blusztajn J. K., Yamaguchi H., Wisniewski T., Saido T. C., Selkoe D. J. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3:1996;16-32.
58. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., Cotman C. W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
59. Mann D. M., Marcyniuk B., Yates P. O., Neary D., Snowden J. S. The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol. Appl. Neurobiol. 14:1988;177-195.
60. Mckhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
61. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., Van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
62. Morris J. C., Heyman A., Mohs R. C., Hughes J. P., Van Belle G., Fillenbaum G., Mellits E. D., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 39:1989;1159-1165.
63. Morris J. C. The clinical dementia rating (CDR): Current version and scoring rules. Arch. Neurol. 43:1993;2412-2414.
64. Morris J. C., Storandt M., McKeel D. W. J., Rubin E. H., Price J. L., Grant E. A., Berg L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 46:1996;707-719.
65. Mortimer J. A. Do psychological risk factors contribute to Alzheimer's disease. Henderson A. S., Henderson J. H. Etiology of Dementia of Alzheimer's Type. 1988;39-52 Wiley, New York.
66. Mufson E. J., Lavine N., Jaffar S., Kordower J. H., Quirion R., Saragovi H. U. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:1997;91-103.
67. Nelson H. E. National Adult Reading Test (NART) Test Manual. 1982;NFER-NELSON Publishing.
68. Nielson K. A., Cummings B. J., Cotman C. W. Constructional apraxia in Alzheimer's disease correlates with neuritic neuropathology in occipital cortex. Brain Res. 741:1996;284-293.
69. Nochlin D., Van Belle G., Bird T. D., Sumi S. M. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 7:1993;212-222.
70. Petersen R. C., Smith G. E., Ivnik R. J., Tangalos E. G., Schaid D. J., Thibodeau S. N., Kokmen E., Waring S. C., Kurland L. T. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 273:1995;1274-1278.
71. Pittman J., Andrews H., Tatemichi T., Link B., Struening E., Stern Y., Mayeux R. Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis. Arch. Neurol. 49:1992;461-467.
72. Price J. L., Davis P. B., Morris J. C., White D. L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 12:1991;295-312.
73. Raven J. C., Court J. H., Raven J. Standard Progressive Matrices - 1992 ed., Raven Manual: Section 3. 1992;Oxford Psychologists, Oxford.
74. Rosene D. L., Van Hoesen G. W. The hippocampal formation of the primate. Jones E. G. The Cerebral Cortex. 1987;345-456 Plenum, New York.
75. Roses A. D. Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease [see comments]. J. Neuropathol. Exp. Neurol. 53:1994;429-437.
76. Roses A. D. Alzheimer diseases: A model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am. J. Med. Genet. 81:1998;49-57.
77. Rubin E. H., Morris J. C., Grant E. A., Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch. Neurol. 46:1989;379-382.
78. Samuel W., Terry R. D., Deteresa R., Butters N., Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch. Neurol. 51:1994;772-778.
79. Selkoe D. J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
80. Selkoe D. J. Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
81. Sloane J. A., Pietropaolo M. F., Rosene D. L., Moss M. B., Peters A., Kemper T., Abraham C. R. Lack of correlation between plaque burden and cognition in the aged monkey. Acta Neuropathol. (Berl.). 94:1997;471-478.
82. Smith A. Symbol Digit Modalities Test Manual-R. 1984;Western Psychological, Los Angeles.
83. Smith G., Ivnik R. J., Petersen R. C., Malec J. F., Kokmen E., Tangalos E. Age-associated memory impairment diagnoses: Problems of reliability and concerns for terminology. Psychol. Aging. 6:1991;551-558.
84. Snowdon, D. A., S. J. Kemper, J. A. Mortimer, L. H. Greiner, D. R. Wekstein, and W. R. Markesbery. 1996. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study [see comments]. 275: 528-532.
85. Solodkin, A., and G. W. Van Hoesen. 1996. Entorhinal cortex modules of the human brain. J. Comp. Neurol.365: 610-617; Stern, Y., H. Andrews, J. Pittman, M. Sano, T. Tatemichi, R. Lantigua, and R. Mayeux. 1992. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch. Neurol.49: 453-460.
86. Solodkin, A., and G. W. Van Hoesen. 1996. Entorhinal cortex modules of the human brain. J. Comp. Neurol.365: 610-617; Stern, Y., H. Andrews, J. Pittman, M. Sano, T. Tatemichi, R. Lantigua, and R. Mayeux. 1992. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch. Neurol.49: 453-460.
87. Stern Y., Gurland B., Tatemichi T. K., Tang M. X., Wilder D., Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease [see comments]. JAMA. 271:1994;1004-1010.
88. Strittmatter W. J., Roses A. D. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:1995;4725-4727.
89. Sze C. I., Troncoso J. C., Kawas C., Mouton P., Price D. L., Martin L. J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;933-944.
90. Terry R. D., Masliah E., Salmon D. P., Butters N., Deteresa R., Hill R., Hansen L. A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
91. Warzok R. W., Kessler C., Apel G., Schwarz A., Egensperger R., Schreiber D., Herbst E. W., Wolf E., Walther R., Walker L. C. Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly. Alzheimer Dis. Assoc. Disord. 12:1998;33-39.
92. Wechsler D. Wechsler Memory Scale - Revised Manual. 1987;Psychological Corporation, New York.
93. Welsh K. A., Butters N., Mohs R. C., Beekly D., Edland S., Fillenbaum G., Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 44:1994;609-614.
94. Wilcock G. K., Esiri M. M. Plaques, tangles and dementia. A quantitative study. J. Neurol. Sci. 56:1982;343-356.
95. Zola-Morgan S., Squire L. R., Ramus S. J. Severity of memory impairment in monkeys as a function of locus and extent of damage within the medial temporal lobe memory system [see comments]. Hippocampus. 4:1994;483-495.